AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 57 filers reported holding AKCEA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $159,000 | +45.9% | 8,759 | +10.1% | 0.00% | – |
| Q2 2020 | $109,000 | +73.0% | 7,959 | +82.9% | 0.00% | – |
| Q1 2020 | $63,000 | -67.7% | 4,351 | -62.5% | 0.00% | – |
| Q4 2019 | $195,000 | +242.1% | 11,606 | +204.2% | 0.00% | – |
| Q3 2019 | $57,000 | -46.7% | 3,815 | -18.1% | 0.00% | – |
| Q2 2019 | $107,000 | -30.1% | 4,659 | -14.3% | 0.00% | – |
| Q1 2019 | $153,000 | +17.7% | 5,436 | +24.4% | 0.00% | – |
| Q4 2018 | $130,000 | -94.6% | 4,370 | -93.6% | 0.00% | -100.0% |
| Q3 2018 | $2,397,000 | +20.9% | 68,466 | -18.1% | 0.00% | 0.0% |
| Q2 2018 | $1,982,000 | +146.5% | 83,616 | +165.7% | 0.00% | – |
| Q1 2018 | $804,000 | +34.0% | 31,470 | -9.1% | 0.00% | – |
| Q4 2017 | $600,000 | -26.3% | 34,624 | +17.4% | 0.00% | -100.0% |
| Q3 2017 | $814,000 | – | 29,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |